Cassava Sciences settles SEC charges for $40M over misleading Alzheimer's drug trial results, ex-CEO and SVP also face negligence charges.

AUSTIN, Texas, Sept. 26, 2024 (GLOBE NEWSWIRE) -- (“Cassava” or the “Company”) (Nasdaq: SAVA), a biotechnology company ...

The SEC also said Dr. Hoau-Yan Wang, a Cassava consultant, was charged with manipulating the reported clinical trial results. Without admitting or denying the violations, Wang agreed to cease and ...

The Securities and Exchange Commission alleged that a researcher for the company manipulated trial data to make its drug ...

Cassava and former executives were charged Thursday by the SEC with making misleading claims in 2020 about trials for the ...

Relatedly, the SEC also charged Hoau-Yan Wang, a Cassava consultant and an associate professor at the City University of New York's Medical School, for manipulating the reported clinical trial results ...

After a third review of safety data, an independent board recommended two trials of simufilam for Alzheimer's continue ...

These are the most popular stories from the Wall Street Journal. These stories have not been verified and we cannot vouch their accuracy. U.S.

The event, reportedly attended by over 10,500 people, highlighted the talents of the musicians while emphasizing the importance of inclusion. Information ...

New York City Mayor Eric Adams has been charged with bribery and illegally soliciting a campaign contribution from a foreign national, according to a federal indictment unsealed on Thursday ...

In the Pact for the Future UN Member States pledged to do more to fight the climate crisis, a subject that has dominated several sessions at UN Headquarters this week.